Process for preparing substituted 2,3-dihydrobenzofuran
    1.
    发明授权
    Process for preparing substituted 2,3-dihydrobenzofuran 失效
    取代2,3-二氢苯并呋喃的制备方法

    公开(公告)号:US4564691A

    公开(公告)日:1986-01-14

    申请号:US602215

    申请日:1984-04-19

    摘要: A process is provided for preparing a substituted 2,3-dihydrobenzofuran of the general formula ##STR1## in which R.sub.a is hydrogen, halogen, alkyl, straight or branched having from 1 to 4 carbon atoms, aryl, alkaryl, --OH, --OR.sub.3, --N(R.sub.d).sub.2, where R.sub.3 and R.sub.d are alkyl, straight or branched having from 1 to 4 carbon atoms; R.sub.b is alkyl, straight or branched, having from 1 to 6 carbon atoms, aryl, alkaryl; and R.sub.c is hydrogen or the same as R.sub.b, by the rearrangement of a 1,1-bis(2-hydroxybenzene) alkyl and/or aryl-ethane, in the presence of catalytic amounts of a mineral acid or organic acid such as phosphoric, sulfuric or p-toluenesulfonic, at elevated temperatures from 180.degree. to 250.degree. C., and withdrawing the resulting products from the reaction mixture as they are formed. The starting 1,1-bis(2-hydroxybenzene) alkyl and/or aryl-ethane compounds may be obtained by the catalyzed reaction of a substituted biphenol with an aldehyde. The substituted 2,3-dihydrobenzofurans are useful in the manufacture of pesticides.

    摘要翻译: 提供了制备通式为“IMAGE”的取代2,3-二氢苯并呋喃的方法,其中Ra为氢,卤素,具有1-4个碳原子的直链或支链的烷基,芳基,烷芳基,-OH,-OR3 ,-N(Rd)2,其中R3和Rd是具有1至4个碳原子的直链或支链烷基; Rb是具有1-6个碳原子的直链或支链烷基,芳基,烷芳基; 和Rc是氢或与Rb相同,通过在催化量的无机酸或有机酸如磷酸的存在下重新配置1,1-双(2-羟基苯)烷基和/或芳基 - 乙烷, 硫酸或对甲苯磺酸,在180℃至250℃的升高温度下,在反应混合物形成时从所得反应混合物中取出。 起始的1,1-双(2-羟基苯)烷基和/或芳基 - 乙烷化合物可以通过取代的联苯酚与醛的催化反应获得。 取代的2,3-二氢苯并呋喃可用于制造农药。

    Process for the preparation of solid polymeric stabilizer compounds
    2.
    发明授权
    Process for the preparation of solid polymeric stabilizer compounds 失效
    固体高分子稳定剂化合物的制备方法

    公开(公告)号:US4833211A

    公开(公告)日:1989-05-23

    申请号:US19881

    申请日:1987-02-27

    CPC分类号: C08F8/10

    摘要: Solid polymeric stabilizer compound containing the hydroxybenzophenone function, having the general formula (I): ##STR1## wherein: m=from 0.01 to 0.99 (preferably from 0.1 to 0.6);l=from 0.99 to 0.01 (preferably from 0.9 to 0.4):m+l=1;R=H, --OH, --OR" (R"+(C.sub.1 -C.sub.20)-alkyl; aryl, alkylaryl cycloalkyl). halogen, (C.sub.1 -C.sub.20)-alkyl, cycloalkyl;R'=H, (C.sub.1 -C.sub.20)-alkyl, cycloalkyl.Also the process for preparing said solid polymeric stabilizers and the stabilized polymeric compositions comprising at least an organic polymer and a stabilizing amount of said solid polymeric stabilizers are disclosed.

    摘要翻译: 具有通式(I)的羟基二苯甲酮功能的固体高分子稳定剂化合物:其中:m = 0.01〜0.99(优选为0.1〜0.6)。 l = 0.99至0.01(优选0.9至0.4):m + 1 = 1; R = H,-OH,-OR“(R”+(C 1 -C 20) - 烷基;芳基,烷基芳基环烷基)。 卤素,(C 1 -C 20) - 烷基,环烷基; R'= H,(C 1 -C 20) - 烷基,环烷基。 还公开了制备所述固体聚合物稳定剂和包含至少一种有机聚合物和稳定量的所述固体聚合物稳定剂的稳定化聚合物组合物的方法。

    TREATMENT WITH CYTOKINES
    6.
    发明申请
    TREATMENT WITH CYTOKINES 审中-公开
    用细胞因子治疗

    公开(公告)号:US20120214866A1

    公开(公告)日:2012-08-23

    申请号:US13356374

    申请日:2012-01-23

    摘要: An inflammatory process is suggested to be involved in the pathogenesis of Alzheimer's disease (AD), a neurodegenerative disorder characterized by the presence of neuritic plaques within the cerebral cortex that are mainly composed of a small insoluble protein of 40-42 aminoacids (amyloid protein). Amyloid-specific Interleukin-10 (IL-10) generation is found to be selectively and significantly reduced in AD patients (p=0.023). The genotype associated with high IL-10 production is extremely infrequent in AD individuals (2% vs. 28%). The presence of low/intermediate-IL-10-producing genotypes (GCC/ATA; ATA/ATA) was associated with an earlier age at disease onset and (ACC/ACC; ACC/ATA) with an accelerated rate of disease progression/severity and with amyloid-specific impairment of IL-10 production. This relationship is independent of ApoE gene polymorphism. These results support the use of anti-inflammatory compounds in the therapy of this disease.

    摘要翻译: 建议炎症过程参与阿尔茨海默病(AD)的发病机制,阿尔茨海默氏病(AD)是一种以大脑皮层内存在神经突斑为特征的神经变性疾病,主要由40-42个氨基酸(淀粉样蛋白)的小不溶性蛋白质组成, 。 发现AD患者淀粉样蛋白特异性白细胞介素-10(IL-10)代被选择性地显着降低(p = 0.023)。 与高IL-10产生相关的基因型在AD个体中极少(2%vs. 28%)。 低/中等IL-10产生基因型(GCC / ATA; ATA / ATA)的存在与疾病发病的早期年龄和(ACC / ACC; ACC / ATA)相关,具有加速的疾病进展/严重程度 并具有IL-10产生的淀粉样蛋白特异性损伤。 这种关系与ApoE基因多态性无关。 这些结果支持在治疗这种疾病中使用抗炎化合物。

    .sigma. AND .pi. ORGANIC COMPLEXES OF TRANSITION METALS AND PROCESS FOR
THE PREPARATION THEREOF
    9.
    发明授权
    .sigma. AND .pi. ORGANIC COMPLEXES OF TRANSITION METALS AND PROCESS FOR THE PREPARATION THEREOF 失效
    {94 {0和{90 {0有机金属过渡复合物及其制备方法

    公开(公告)号:US4042609A

    公开(公告)日:1977-08-16

    申请号:US654350

    申请日:1976-02-02

    摘要: A compound having catalytic properties which is a .sigma. or .pi. organic complex of a transition metal represented by the general formula: M (A).sub.n (L-C) (L).sub.m, wherein M is Ir or Re; L is a member of the group consisting of alkyl and aryl phosphines; (L-C) is (a) an alkyl or aryl phosphine ligand wherein a C-H bond is reacted with the central M atom to which the ligand is coordinated, and a metal-carbon bond is formed, or (b) a .pi.-allyl radical; A is a linear monoolefin having from 2 to 5 carbon atoms or a cyclic monoolefin having from 6 to 8 carbon atoms; n is a number in the range of 0 to 2 and is always zero when L-C is a .pi.-allyl radical; and m is a number from 1 to 3 which satisfies the valence of M, is prepared by reacting a hydride complex represented by the general formula: MHLn.sub.1 wherein M and L have the meaning given above, x is in the range from 5 to 7 and n.sub.1 is a number from 2 to 3 which satisfies the valence of M, with a linear monoolefin having from 2 to 5 carbon atoms or a cyclic monoolefin having from 6 to 8 carbon atoms.

    摘要翻译: 具有催化性质的化合物,其为由通式M(A)n(L-C)(L)m表示的过渡金属的σ或π有机络合物,其中M为Ir或Re; L是由烷基和芳基膦组成的组的成员; (L-C)是(a)烷基或芳基膦配体,其中C-H键与配位体配位的中心M原子反应,形成金属 - 碳键,或(b)吡咯烷基; A是具有2至5个碳原子的直链单烯烃或具有6至8个碳原子的环状单烯烃; n为0〜2的数,当L-C为吡啶基时,该数为0。 m为1〜3的数,其满足M的化合价,通过使由通式MHLn1表示的氢化物配合物反应制备,其中M和L具有上述含义,x在5至7的范围内, n1是2至3的数,其满足M的价数,具有2至5个碳原子的直链单烯烃或具有6至8个碳原子的环状单烯烃。